NR507 ADVANCED PATHOPHYSIOLOGY FINAL EXAM WITH ACCURATE QUESTIONS AND CORRECT SOLUTIONS GRADED A+|GUARANTEED TO PASS 100%|

1. Treatment options for Bipolar Disorder ANSWER Cognitive behavioral therapy, psychoeducation, family-focused therapy, mindfulness-based cognitive therapy, and integrated collaborative care. 2. First-line pharmacotherapy for Panic Disorder ANSWER SSRIs. 3. Psychotherapeutic approach for Panic Disorder ANSWER Cognitive behavioral therapy. 4. Lifestyle modifications for Panic Disorder ANSWER Stress management and sleep hygiene. 5. Complications from Panic Disorder ANSWER Agoraphobia, depression, substance abuse, impaired social and occupational functioning, increased risk of suicide, and chronic anxiety. 6. Key symptoms of a manic episode ANSWER Elevated mood, increased energy, decreased need for sleep, grandiosity, racing thoughts, impulsivity, distractibility, increased talkativeness, and hyperactivity. 7. Positive symptoms of schizophrenia ANSWER Hallucinations, delusions, formal thought disorder, and bizarre behavior. 8. Negative symptoms of schizophrenia ANSWER Flattened affect, alogia, anhedonia, attention deficits, and apathy. 9. Cognitive symptoms associated with schizophrenia ANSWER Inability to perform daily tasks requiring attention and planning. 10. Structural brain abnormalities in schizophrenia ANSWER Enlargement of the lateral and third ventricles and widening of frontocortical fissures and sulci. 11. Most common disorder of thyroid function ANSWER Hypothyroidism. 12. Prevalence of hypothyroidism in the U.S. population ANSWER Affects between 0.1% and 2% of the population, more common in women and the elderly. 13. Most common cause of hypothyroidism ANSWER Hashimoto's Thyroiditis. 14. Autoantibodies produced in Hashimoto's Thyroiditis ANSWER Anti-thyroid peroxidase (TPO) antibodies and anti-thyroglobulin antibodies. 15. Goal of treatment for hypothyroidism ANSWER To restore thyroid hormone levels to within the normal reference range. 16. Key marker for assessing hypothyroidism treatment effectiveness TSH ANSWER TSH (Thyroid-stimulating hormone). 17. ANSWER Thyroid-stimulating hormone. 18. What hormone is released by the anterior pituitary? ANSWER Thyroid stimulating hormone 19. General exam findings in hyperthyroidism ANSWER Weight loss, tachycardia, and warm skin. 20. Neurological exam findings in hyperthyroidism ANSWER Tremors, hyperreflexia, and nervousness. 21. Treatment options for hyperthyroidism ANSWER Antithyroid drug therapy (methimazole or propylthiouracil), radioactive iodine therapy, and surgery. 22. Goal of radioactive iodine ablation for Grave's disease ANSWER To destroy overactive thyroid tissue. 23. ADA Diagnostic Criteria for Diabetes based on HbA1c ANSWER HbA1c ≥6.5% as measured in a DCCT referenced assay. 24. Fasting plasma glucose level indicating diabetes ANSWER FPG ≥126 mg/dL (7.0 mmol/L). The NP evaluates the effectiveness of the treatment. 25. Lifestyle modifications for GERD patients ANSWER Lifestyle modifications may include dietary changes, weight management, and avoiding triggers. 26. Medications commonly used to treat GERD ANSWER Antacids, H2 receptor antagonists, proton pump inhibitors, and prokinetic agents. 27. Significance of esophageal motility disorders in GERD ANSWER Impaired esophageal peristalsis reduces esophageal clearance, leading to pooling of gastric acid. 28. Role of the lower esophageal sphincter (LES) in GERD ANSWER The LES dysfunction allows gastric acid to flow back into the esophagus, contributing to GERD. 29. Potential complications of untreated appendicitis ANSWER Untreated appendicitis can lead to perforation and systemic response. 30. Importance of C-reactive protein in diagnosing appendicitis ANSWER Increased C-reactive protein indicates systemic inflammation associated with appendicitis. 31. Typical pain pattern associated with appendicitis ANSWER Pain typically starts as periumbilical pain and later localizes to the right lower quadrant (RLQ). 32. Role of imaging in diagnosing appendicitis ANSWER Imaging such as abdominal ultrasound, CT scan, and MRI are used to confirm the diagnosis of appendicitis. 33. Major risk factor for GERD associated with Hiatal Hernia ANSWER Diaphragmatic weakness. 34. Contributing factors to Hiatal Hernia ANSWER Aging, obesity, pregnancy, increased intra abdominal pressure (chronic coughing or Valsalva maneuver), and structural abnormalities of the diaphragm. 35. Hiatal Hernia ANSWER A condition caused by aging, obesity, pregnancy, increased intra-abdominal pressure (chronic coughing or Valsalva maneuver), and structural abnormalities of the diaphragm. 36. Lifestyle modification for Hiatal Hernia ANSWER Eating small, frequent meals. 37. Medications for Hiatal Hernia ANSWER Antacids, H2 receptor blockers, proton pump inhibitors, and prokinetic agents. 38. Primary cause of Duodenal Ulcer ANSWER H. pylori infection. 39. Aggressive factors in Duodenal Ulcer ANSWER Gastric acid, pepsin, H. pylori, and NSAIDs. 40. Defensive factors against Duodenal Ulcer ANSWER Mucus-bicarbonate layer, prostaglandins, and cellular repair mechanisms. 41. Characteristic symptom of Duodenal Ulcer ANSWER Chronic intermittent pain in the epigastric area, typically occurring 30 minutes to 2 hours after eating. 42. Gold standard for diagnosing Peptic Ulcer Disease (PUD) ANSWER Endoscopy. 43. Common risk factors for Gastric Ulcer ANSWER H. pylori infection, NSAIDs, smoking, excessive alcohol consumption, stress, family history, and age. 44. Difference between erosion and ulcer in Peptic Ulcer Disease ANSWER An ulcer is a deeper break in the mucosal lining compared to an erosion. 45. Protective mechanisms against Peptic Ulcer Disease ANSWER Mucus and bicarbonate secretion, prostaglandins, mucosal blood flow, and epithelial cell renewal. 46. Symptoms associated with Ulcerative Colitis ANSWER Diarrhea, abdominal pain and cramping, rectal bleeding, urgency to defecate, and fatigue. 47. Pathophysiological features of Crohn's Disease ANSWER Genetic predisposition, immune dysregulation, environmental factors, disruption of the intestinal barrier, and transmural inflammation. 48. Treatments available for Crohn's Disease ANSWER Smoking cessation, steroids, immunosuppressants, and biologics such as anti TNF-alpha and IL inhibitors. 49. Cirrhosis ANSWER The late stage of liver scarring (fibrosis) caused by long-term liver damage. 50. Common diagnostic approaches for Peptic Ulcer Disease ANSWER Endoscopy, lab tests (CBC, stool for occult blood, serum urea and electrolytes, H. pylori testing), and imaging studies (abdominal ultrasound, CT scan). 51. Lifestyle modifications for Peptic Ulcer Disease ANSWER Avoidance of NSAIDs, smoking cessation, and dietary changes. 52. Symptoms of Duodenal Ulcer ANSWER Chronic intermittent epigastric pain, often occurring on an empty stomach or at night. 53. Medications for Duodenal Ulcer ANSWER Proton pump inhibitors, H2-receptor blockers, antibiotics, antacids, and cytoprotective agents. 54. Role of H. pylori in Peptic Ulcer Disease ANSWER H. pylori infection is a major aggressive factor contributing to ulcer formation. 55. Complications associated with Crohn's Disease ANSWER Strictures, fistulas, and abscesses due to transmural inflammation. 56. Impact of stress on Gastric Ulcer risk ANSWER Stress (both physical and psychological) is a recognized risk factor for Gastric Ulcer. 57. Hepatocyte damage and inflammation in cirrhosis ANSWER Chronic injury. 58. Key features of cirrhosis pathophysiology ANSWER Fibrosis, nodular regeneration, vascular changes, liver dysfunction, and complications. 59. Portal hypertension ANSWER It is characterized by structural changes in the liver, increased resistance to blood flow, formation of collateral circulation, and hyperdynamic circulation. 60. Complications of portal hypertension in cirrhosis ANSWER Variceal bleeding, ascites, splenomegaly, hepatic encephalopathy, and hepatorenal syndrome.